Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL
Recall D-0080-2018, part of FDA recall event 78503. See PharMEDium Services's company page.
PharMEDium Services, LLC. started this Class II drug recall on Oct 13, 2017 (voluntary: firm initiated); FDA lists it as terminated, terminated Jan 24, 2020.
- Classification: Class II
- Started: Oct 13, 2017
- Status: Terminated
Why It Was Recalled
Class IISuperpotent drug: out of specification result for potency
Record
- Product
- Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40
- Quantity
- 499 syringes
- Lots and codes
- Lot#: 172820134M, Exp 01/18
- Distribution
- CA, IL
- Recalling firm
- PharMEDium Services, LLC., Memphis, TN, United States
- How the firm notified
- Telephone
- FDA classified
- Nov 14, 2017
PharMEDium Services, LLC.'s Other Recalls
Newest first, one product per recall event; search them all- 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton,…D-0374-2019 · Class II · Jan 2, 2019 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports